Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions

S Bhalla, S Mehan, A Khan, MU Rehman - Neuroscience & Biobehavioral …, 2022 - Elsevier
Abstract Insulin-like growth factor-1 (IGF-1), a pleiotropic polypeptide, plays an essential role
in CNS development and maturation. Glucagon-like peptide-1 (GLP-1) is an endogenous …

Neurotrophic and neuroregenerative effects of GH/IGF1

VE Bianchi, V Locatelli, L Rizzi - International journal of molecular …, 2017 - mdpi.com
Introduction. Human neurodegenerative diseases increase progressively with age and
present a high social and economic burden. Growth hormone (GH) and insulin-like growth …

The role of insulin-like growth factors and insulin-like growth factor–binding proteins in the nervous system

MS Lewitt, GW Boyd - Biochemistry insights, 2019 - journals.sagepub.com
The insulin-like growth factors (IGF-I and IGF-II) and their receptors are widely expressed in
nervous tissue from early embryonic life. They also cross the blood brain barriers by active …

Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects

FH Kobeissy - 2015 - books.google.com
With the contribution from more than one hundred CNS neurotrauma experts, this book
provides a comprehensive and up-to-date account on the latest developments in the area of …

Pituitary dysfunction after traumatic brain injury: a clinical and pathophysiological approach

F Tanriverdi, HJ Schneider, G Aimaretti… - Endocrine …, 2015 - academic.oup.com
Traumatic brain injury (TBI) is a growing public health problem worldwide and is a leading
cause of death and disability. The causes of TBI include motor vehicle accidents, which are …

Role of IGF-I in skeletal muscle mass maintenance

DR Clemmons - Trends in Endocrinology & Metabolism, 2009 - cell.com
The recent identification of signaling elements that regulate skeletal muscle protein balance
has provided the opportunity to determine how IGF-I alters these processes. Animal studies …

A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury

KW McConeghy, J Hatton, L Hughes, AM Cook - CNS drugs, 2012 - Springer
Traumatic brain injury (TBI) affects 1.6 million Americans annually. The injury severity
impacts the overall outcome and likelihood for survival. Current treatment of acute TBI …

Effect of growth hormone replacement therapy on cognition after traumatic brain injury

WM High Jr, M Briones-Galang, JA Clark… - Journal of …, 2010 - liebertpub.com
Traumatic brain injury (TBI) is a major public health issue, and yet medical science has little
to offer for the persistent symptoms that prevent many of these individuals from fully re …

Long-term consequences of traumatic brain injury in bone metabolism

NM Bajwa, C Kesavan, S Mohan - Frontiers in neurology, 2018 - frontiersin.org
Traumatic brain injury (TBI) leads to long-term cognitive, behavioral, affective deficits, and
increase neurodegenerative diseases. It is only in recent years that there is growing …

Stem cells and combination therapy for the treatment of traumatic brain injury

AS Dekmak, S Mantash, A Shaito, A Toutonji… - Behavioural Brain …, 2018 - Elsevier
TBI is a nondegenerative, noncongenital insult to the brain from an external mechanical
force; for instance a violent blow in a car accident. It is a complex injury with a broad …